We are live on ! Find out more
IMVTU

Immunovant, Inc. Units
IMVTU

Delisted

IMVTU was delisted on the 5th of June, 2020.

Back to rankings

7 hedge funds and large institutions have $60M invested in Immunovant, Inc. Units in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+7
Holders Change %
–
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$23.3M
2
EAM
Eventide Asset Management
Massachusetts
+$14.6M
3
PA
Perceptive Advisors
New York
+$8.62M
4
PVI
Pura Vida Investments
New York
+$3.56M
5
SFM
Sphera Funds Management
Israel
+$2.15M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Cormorant Asset Management
Massachusetts
$26.5M +$23.3M +1,080,000 New
EAM
2
Eventide Asset Management
Massachusetts
$16.9M +$14.6M +680,000 New
PA
3
Perceptive Advisors
New York
$9.95M +$8.62M +400,000 New
PVI
4
Pura Vida Investments
New York
$4.05M +$3.56M +165,170 New
SFM
5
Sphera Funds Management
Israel
$2.49M +$2.15M +100,000 New
UBS Group
6
UBS Group
Switzerland
$26K +$23.2K +1,079 New
TRCT
7
Tower Research Capital (TRC)
New York
$4K +$3.36K +156 New

IMVTU Hedge Fund Activity: Q4 2019 in Review

7 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Immunovant, Inc. Units (IMVTU) for Q4 2019, worth a combined $60M.

Buyers outnumbered sellers: 7 funds opened new IMVTU positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $23.3M.

  • 7 institutional investors held Immunovant, Inc. Units (IMVTU) as of Q4 2019, up from 0 in Q3 2019.
  • Funds reported $60M of Immunovant, Inc. Units stock for Q4 2019.
  • 7 funds opened new Immunovant, Inc. Units positions in Q4 2019 and 0 closed out, a net change of +7 holders.
  • The largest Immunovant, Inc. Units buyer in Q4 2019 was Cormorant Asset Management, an estimated $23.3M added.

Based on aggregated 13F filings for Q4 2019.